SUMMARY
This is AI generated summarization, which may have errors. For context, always refer to the full article.
Researchers sounded the alarm about drug-resistant tuberculosis in the Lancet medical journal. They studied 8 countries and found 43.7% of TB patients did not respond to at least one second-line TB drug, used when the most powerful first-line drugs fail. The study covered Estonia, Latvia, Peru, the Philippines, Russia, South Africa, South Korea and Thailand. In the Philippines, part of what causes the problem is the over-prescription of antibiotics or the failure to take the full prescribed course, which can allow the bacteria which causes TB to develop resistance to the drug.
Read more on Rappler
Read more on Rappler
Add a comment
How does this make you feel?
Loading
There are no comments yet. Add your comment to start the conversation.